The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
7-(benzyloxy)-2-oxo-N-phenyl-2H-chromene-3-carboxamide ID: ALA4788587
PubChem CID: 162668516
Max Phase: Preclinical
Molecular Formula: C23H17NO4
Molecular Weight: 371.39
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(Nc1ccccc1)c1cc2ccc(OCc3ccccc3)cc2oc1=O
Standard InChI: InChI=1S/C23H17NO4/c25-22(24-18-9-5-2-6-10-18)20-13-17-11-12-19(14-21(17)28-23(20)26)27-15-16-7-3-1-4-8-16/h1-14H,15H2,(H,24,25)
Standard InChI Key: CVPLBJIFGTZNIV-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 31 0 0 0 0 0 0 0 0999 V2000
34.1184 -26.9425 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1172 -27.7620 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8253 -28.1710 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5349 -27.7616 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.5321 -26.9389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.8235 -26.5336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2383 -26.5277 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.9475 -26.9336 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.2433 -28.1691 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
36.9504 -27.7594 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6591 -28.1662 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
37.6538 -26.5224 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.6508 -25.7053 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.3629 -26.9285 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.4092 -28.1701 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
32.7018 -27.7609 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9938 -28.1690 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2851 -27.7612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5775 -28.1685 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5765 -28.9866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.2888 -29.3956 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.9935 -28.9859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0692 -26.5173 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7740 -26.9250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4798 -26.5145 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.4773 -25.6965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.7631 -25.2906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.0603 -25.7034 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 2 0
4 9 1 0
8 10 1 0
9 10 1 0
10 11 2 0
8 12 1 0
12 13 2 0
12 14 1 0
2 15 1 0
15 16 1 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
23 14 1 0
23 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 23 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 371.39Molecular Weight (Monoisotopic): 371.1158AlogP: 4.62#Rotatable Bonds: 5Polar Surface Area: 68.54Molecular Species: NEUTRALHBA: 4HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 13.14CX Basic pKa: ┄CX LogP: 4.37CX LogD: 4.37Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.52Np Likeness Score: -0.86
References 1. Ji H,Tan Y,Gan N,Zhang J,Li S,Zheng X,Wang Z,Yi W. (2021) Synthesis and anticancer activity of new coumarin-3-carboxylic acid derivatives as potential lactatetransportinhibitors., 29 [PMID:33221062 ] [10.1016/j.bmc.2020.115870 ]